EE200200218A - 2-imidasolüül-asendatud karbinoolide kasutamine ravimi valmistamiseks isheemilistest seisunditest tingitud haiguste raviks või profülaktikaks - Google Patents

2-imidasolüül-asendatud karbinoolide kasutamine ravimi valmistamiseks isheemilistest seisunditest tingitud haiguste raviks või profülaktikaks

Info

Publication number
EE200200218A
EE200200218A EEP200200218A EEP200200218A EE200200218A EE 200200218 A EE200200218 A EE 200200218A EE P200200218 A EEP200200218 A EE P200200218A EE P200200218 A EEP200200218 A EE P200200218A EE 200200218 A EE200200218 A EE 200200218A
Authority
EE
Estonia
Prior art keywords
prophylaxis
imidazolyl
medicament
manufacture
treatment
Prior art date
Application number
EEP200200218A
Other languages
English (en)
Inventor
Weichert Andreas
Albus Udo
Jansen Hans-Willi
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of EE200200218A publication Critical patent/EE200200218A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
EEP200200218A 1999-10-27 2000-10-14 2-imidasolüül-asendatud karbinoolide kasutamine ravimi valmistamiseks isheemilistest seisunditest tingitud haiguste raviks või profülaktikaks EE200200218A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19951701A DE19951701A1 (de) 1999-10-27 1999-10-27 Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten
PCT/EP2000/010126 WO2001030327A2 (de) 1999-10-27 2000-10-14 Verwendung von 2-imidazolyl-substituierten carbinolen zur herstellung eines medikaments zur behandlung oder prophylaxe von durch ischämischen zuständen

Publications (1)

Publication Number Publication Date
EE200200218A true EE200200218A (et) 2003-06-16

Family

ID=7927020

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200218A EE200200218A (et) 1999-10-27 2000-10-14 2-imidasolüül-asendatud karbinoolide kasutamine ravimi valmistamiseks isheemilistest seisunditest tingitud haiguste raviks või profülaktikaks

Country Status (30)

Country Link
US (1) US6291502B1 (et)
EP (1) EP1227811B1 (et)
JP (1) JP2003512419A (et)
KR (1) KR20020060213A (et)
CN (1) CN1188125C (et)
AR (1) AR026241A1 (et)
AT (1) ATE257702T1 (et)
AU (1) AU778836B2 (et)
BR (1) BR0015024A (et)
CA (1) CA2388956A1 (et)
CZ (1) CZ295925B6 (et)
DE (2) DE19951701A1 (et)
DK (1) DK1227811T3 (et)
EE (1) EE200200218A (et)
ES (1) ES2213621T3 (et)
HK (1) HK1048938B (et)
HR (1) HRP20020362A2 (et)
HU (1) HUP0203213A3 (et)
IL (1) IL149208A0 (et)
NO (1) NO20021909L (et)
NZ (1) NZ518586A (et)
PL (1) PL355911A1 (et)
PT (1) PT1227811E (et)
RU (1) RU2257205C2 (et)
SK (1) SK5512002A3 (et)
TR (1) TR200201140T2 (et)
TW (1) TWI246424B (et)
WO (1) WO2001030327A2 (et)
YU (1) YU20902A (et)
ZA (1) ZA200203035B (et)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6726829B2 (en) * 1997-04-08 2004-04-27 Scimed Life Systems, Inc. Method of manufacturing a stent
JP4394451B2 (ja) 2002-01-04 2010-01-06 ニューロサーチ、アクティーゼルスカブ カリウムチャネルモジュレーター
US10040767B2 (en) 2014-05-15 2018-08-07 Peloton Therapeutics, Inc. Benzimidazole derivatives and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793407A (fr) * 1971-12-28 1973-06-28 Hoechst Ag Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation
BE794940A (fr) * 1972-02-04 1973-08-02 Gist Brocades Nv Nouveaux composes anorexigenes
US4152441A (en) 1972-02-04 1979-05-01 Gist-Brocades N.V. Analgesic imidazolemethanols
US5063220A (en) * 1988-10-21 1991-11-05 Syntex Pharmaceuticals, Ltd. Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
US6175013B1 (en) * 1994-06-10 2001-01-16 Eli Lilly And Company Imidazolinyl tachykinin receptor antagonists
ATE229019T1 (de) 1996-06-27 2002-12-15 Janssen Pharmaceutica Nv N-4-(heteroarylmethyl)phenyl- heteroarylaminderivate

Also Published As

Publication number Publication date
RU2257205C2 (ru) 2005-07-27
TWI246424B (en) 2006-01-01
PL355911A1 (en) 2004-05-31
CZ20021452A3 (cs) 2002-07-17
EP1227811B1 (de) 2004-01-14
TR200201140T2 (tr) 2002-11-21
IL149208A0 (en) 2002-11-10
AR026241A1 (es) 2003-02-05
CN1188125C (zh) 2005-02-09
ZA200203035B (en) 2003-03-14
CA2388956A1 (en) 2001-05-03
CN1373663A (zh) 2002-10-09
PT1227811E (pt) 2004-05-31
NO20021909D0 (no) 2002-04-23
RU2002113666A (ru) 2004-01-10
ATE257702T1 (de) 2004-01-15
HK1048938B (zh) 2005-06-10
CZ295925B6 (cs) 2005-11-16
WO2001030327A3 (de) 2002-03-14
KR20020060213A (ko) 2002-07-16
SK5512002A3 (en) 2002-08-06
HK1048938A1 (en) 2003-04-25
AU778836B2 (en) 2004-12-23
AU1138201A (en) 2001-05-08
HUP0203213A2 (en) 2003-05-28
HRP20020362A2 (en) 2004-02-29
NZ518586A (en) 2004-07-30
HUP0203213A3 (en) 2003-07-28
DE50005040D1 (de) 2004-02-19
DK1227811T3 (da) 2004-04-19
BR0015024A (pt) 2002-06-18
WO2001030327A2 (de) 2001-05-03
US6291502B1 (en) 2001-09-18
JP2003512419A (ja) 2003-04-02
EP1227811A2 (de) 2002-08-07
DE19951701A1 (de) 2001-05-03
YU20902A (sh) 2004-11-25
ES2213621T3 (es) 2004-09-01
NO20021909L (no) 2002-04-23

Similar Documents

Publication Publication Date Title
PL362711A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
CY2014019I1 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
NO20043000L (no) Et preparat for behandling av nevrocerebrovaskulaere sykdommer
NO20053077D0 (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
NO20033594L (no) Fenetanolamin-derivater for behandling av luftveissykdommer
NO20031443L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
EE200200656A (et) Ravis kasutatavad tropaani derivaadid
WO2001045679A3 (de) Verwendung von chemotherapeutika zur topischen behandlung
AU8622101A (en) Remedies for ischemic diseases
HK1104460A1 (en) Use for the manufacture of a medicament for treatment or prophylaxis of infectious diseases
EE200300537A (et) Meetod madalaannuselise farmatseutilise kompositsiooni tootmiseks
HUP0303988A2 (hu) Azitromicin alkalmzása nem fertőző gyulladásos betegségek kezelésére szolgáló gyógyszerkészítmény előállítására
IT1318514B1 (it) Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
IL163871A0 (en) Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
NO20032006L (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
EE200200218A (et) 2-imidasolüül-asendatud karbinoolide kasutamine ravimi valmistamiseks isheemilistest seisunditest tingitud haiguste raviks või profülaktikaks
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
HK1077216A1 (en) Use of thiazole derivatives for the manufacture ofa medicament for the treatment of chronic obstruc tive pulmonary disease
NO20021710D0 (no) Anvendelse av 2-amino-3,4-dihydro-kinazoliner for fremstilling av et medikament for behandling eller profylakse avsykdommer bevirket av iskemiske tilstander
PT1305314E (pt) Agente terapeutico cristalino
MXPA02006448A (es) Preparacion externa para tratar dermatitis alergica.
HUP0300876A3 (en) Use of diclofenac for the manufacture of medicament for the topical treatment of burns
EE200200374A (et) Enoksapariini kasutamine ajuisheemia raviks rakendatava ravimi valmistamiseks
PL377524A1 (pl) Zastosowanie substancji L-DOPA, jej pochodnych i zawierający te związki środek leczniczy do profilaktyki schorzeń psychotycznych
NO20030762D0 (no) Forbedret spesifisitet i behandling av sykdommer